Circulating IL-6 contributes to the development of atherosclerosis and insulin resistance, the latter being caused by IL-6-induced impairment of the phosphorylation of insulin receptor and insulin receptor substrate-1 by inducing the expression of SOCS-3, a potential inhibitor of insulin signaling [62]. The gene discussed is IL6; the disease is Insulin resistance.